Mark Jacobson, M.A
2021
Compensation breakdown
Non-Equity Incentive Plan | $139,060 |
---|---|
Option Awards | $3,240,166 |
Salary | $409,000 |
Stock Awards | $999,938 |
Other | $6,660 |
Total | $4,794,824 |
MA received $3.2M in option awards, accounting for 68% of the total pay in 2021.
MA also received $139.1K in non-equity incentive plan, $409K in salary, $999.9K in stock awards and $6.7K in other compensation.
Rankings
In 2021, Mark Jacobson, M.A's compensation ranked 2,749th out of 12,415 executives tracked by ExecPay. In other words, MA earned more than 77.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,749 | 78th |
Manufacturing | 1,089 | 80th |
Chemicals And Allied Products | 428 | 82nd |
Drugs | 373 | 82nd |
Pharmaceutical Preparations | 249 | 84th |
Pay ratio
Mark Jacobson, M.A's Pay | $4,794,824 |
---|---|
Median Employee's Pay | $690,964 |
Pay Ratio | 7to 1 |
In 2021, the annual total compensation of Mark Jacobson, M.A was $4,794,824.
The annual total compensation of the median employee at Axsome Therapeutics was $690,964.
The ratio of Mark Jacobson, M.A's pay to the pay of median employee was therefore 7 to one.
MA's colleagues
We found two more compensation records of executives who worked with Mark Jacobson, M.A at Axsome Therapeutics in 2021.